Literature DB >> 3159972

CSF beta-endorphin and beta-lipotropin in Alzheimer's disease and multi-infarct dementia.

R Sulkava, T Erkinjuntti, T Laatikainen.   

Abstract

We measured CSF levels of the opioid peptides beta-endorphin and beta-lipotropin in patients with Alzheimer's disease, multi-infarct dementia and controls. In both dementia groups, the mean concentration of beta-endorphin was significantly lower than in controls. The mean beta-lipotropin levels did not differ significantly in the two groups. The low CSF beta-endorphin level may relate generally to dementia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3159972     DOI: 10.1212/wnl.35.7.1057

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Effects of the opiate antagonist naloxone on learning and memory in patients with multi-infarct dementia.

Authors:  R Sandyk; J Allender; C R Bamford
Journal:  Postgrad Med J       Date:  1987-08       Impact factor: 2.401

2.  CSF beta-endorphin and leu-enkephalin levels in the acute and chronic stages of cerebral infarction.

Authors:  M Kobari; N Ishihara; K Yunoki
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

Review 3.  Opioid system and Alzheimer's disease.

Authors:  Zhiyou Cai; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-04-22       Impact factor: 3.843

Review 4.  Roles of β-Endorphin in Stress, Behavior, Neuroinflammation, and Brain Energy Metabolism.

Authors:  Alexander Pilozzi; Caitlin Carro; Xudong Huang
Journal:  Int J Mol Sci       Date:  2020-12-30       Impact factor: 5.923

5.  Neuropeptide Kyotorphin (Tyrosyl-Arginine) has Decreased Levels in the Cerebro-Spinal Fluid of Alzheimer's Disease Patients: Potential Diagnostic and Pharmacological Implications.

Authors:  Sara Matos Santos; Laura Garcia-Nimo; Sónia Sá Santos; Isaura Tavares; José A Cocho; Miguel A R B Castanho
Journal:  Front Aging Neurosci       Date:  2013-10-30       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.